Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析

【英語タイトル】Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(SWOT20MY0151)・商品コード:SWOT20MY0151
・発行会社(調査会社):GlobalData
・発行日:2019年11月
・ページ数:71
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Becton Dickinson and Co (BDX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company sells its products in the Americas, Europe, the Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.

Becton Dickinson and Co Key Recent Developments

Nov 05,2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance
Oct 23,2019: AdvaMed Statement on BD Sterilization Plant in Georgia
Sep 26,2019: BD announces leadership succession plan
Sep 19,2019: Community Clinics receive grant for Point-of-Care Diagnostics
Aug 29,2019: BD awards $1.2 million in grants to community health centers that help vulnerable patients more effectively manage medications

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Becton Dickinson and Co – Key Facts
Becton Dickinson and Co – Key Employees
Becton Dickinson and Co – Key Employee Biographies
Becton Dickinson and Co – Major Products and Services
Becton Dickinson and Co – History
Becton Dickinson and Co – Company Statement
Becton Dickinson and Co – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit
Section 2 – Company Analysis
Company Overview
Becton Dickinson and Co – Business Description
Business Segment: BD Interventional
Overview
Performance
Business Segment: BD Life Sciences
Overview
Performance
Business Segment: BD Medical
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Greater Asia
Target Markets
Performance
Geographical Segment: Others
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Becton Dickinson and Co – Corporate Strategy
Becton Dickinson and Co – SWOT Analysis
SWOT Analysis – Overview
Becton Dickinson and Co – Strengths
Becton Dickinson and Co – Weaknesses
Becton Dickinson and Co – Opportunities
Becton Dickinson and Co – Threats
Becton Dickinson and Co – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2013 to YTD 2019
Becton Dickinson and Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance
Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia
Sep 26, 2019: BD announces leadership succession plan
Sep 19, 2019: Community Clinics receive grant for Point-of-Care Diagnostics
Aug 29, 2019: BD awards $1.2 million in grants to community health centers that help vulnerable patients more effectively manage medications
Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance
Jul 25, 2019: BD Statement on Georgia facilities
Jun 27, 2019: United States and Indonesia expand collaboration to end tuberculosis
Jun 21, 2019: BD Statement on Voluntary Recall of BD Vacutainer Fluoride Tubes for Blood Alcohol Determinations
Jun 19, 2019: BD Debuts New Software for Flow Cytometry Analysis
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Becton Dickinson and Co, Key Facts
Becton Dickinson and Co, Key Employees
Becton Dickinson and Co, Key Employee Biographies
Becton Dickinson and Co, Major Products and Services
Becton Dickinson and Co, History
Becton Dickinson and Co, Other Locations
Becton Dickinson and Co, Subsidiaries
Becton Dickinson and Co, Business Unit
Becton Dickinson and Co, Key Competitors
Becton Dickinson and Co, Ratios based on current share price
Becton Dickinson and Co, Annual Ratios
Becton Dickinson and Co, Annual Ratios (Cont...1)
Becton Dickinson and Co, Annual Ratios (Cont...2)
Becton Dickinson and Co, Interim Ratios
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2013 to YTD 2019
Becton Dickinson and Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Becton Dickinson and Co, Performance Chart (2015 - 2019)
Becton Dickinson and Co, Ratio Charts
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals by Type, 2013 to YTD 2019

★調査レポート[Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析] (コード:SWOT20MY0151)販売に関する免責事項を必ずご確認ください。
★調査レポート[Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆